A recent study indicates that patients who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who end conventional diet and exercise plans.
Findings released in a leading medical journal demonstrates that while overweight individuals often shed about a fifth of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.
"People using these medications need to be cognizant of the potential of rapid weight regain when the therapy ends," warns researcher Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment weight in about 18 months.
Comparing Therapies
The study, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers emphasize that people who lose weight through lifestyle changes alone usually see a slower creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Doctors believe the mechanism of the drugs is key to understanding the amplified regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in hunger is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Health authorities suggest the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, considering the likelihood of relapse, the treatment should be considered long-term.
This perspective is reinforced by drug manufacturers, who note that the findings "emphasize the long-term character of obesity," akin to managing conditions like diabetes.
Patient Experiences
Users who have discontinued the medication describe a sudden return of hunger.
"I experienced a switch flipping and you become starving," described one woman.
This challenge is worsened if users have not established sustainable lifestyle or habit modifications during treatment.
Widespread Use
Survey data suggest that millions of adults in the UK have used these injections in the past year, with desire remaining high.
- Adoption is greater among females than men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Ultimately, researchers caution that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits relies on ongoing lifestyle support.